CLINICAL_TRIALS
trial_result
· 2013-05-16
Clinical Trial Update: Study of the Efficacy and Safety of Nebivolol in Younger Patients (18 - 54 Years) [Phase 4]
Summary
Phase 4 trial evaluating the efficacy and safety of nebivolol in younger adults (18-54) with hypertension has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Forest Laboratories | Conditions: Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2013-05-16